Case Report: Three cases with allogeneic CIK therapy against solid tumors
We recommend the early postoperative application of CIK cell therapy for solid tumor patients, particularly in cases involving: (1) cancer types with limited chemotherapeutic options, (2) chemotherapy-intolerant patients, (3) cases of chemotherapy failure, and (4) patients who have completed standard chemoradiotherapy regimens.
Authors
- Lili Yao (ORCID: https://orcid.org/0009-0000-3963-5861)
- Junyan Lin
- Xianwu Wang (ORCID: https://orcid.org/0000-0003-2167-2562)
- Yanfei Li (ORCID: https://orcid.org/0000-0002-7370-6763)
- Rui Wang
- Qiuhong Zheng
Institutions
- Union Hospital (HK)
- Xiamen Chang Gung Hospital (CN)
- The Second Affiliated Hospital of Xiamen Medical College
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1658864
- Citations
- 1
- Primary Topic
- Gastrointestinal Tumor Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.81